{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:25:27Z","timestamp":1772223927255,"version":"3.50.1"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1111\/bjd.16738","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T23:44:36Z","timestamp":1525995876000},"page":"978-979","source":"Crossref","is-referenced-by-count":8,"title":["Polysensitivity in delayed cutaneous adverse drug reactions to macrolides, clindamycin and pristinamycin: clinical history and patch testing"],"prefix":"10.1093","volume":"179","author":[{"given":"M.","family":"El Khoury","sequence":"first","affiliation":[{"name":"Department of Dermatology; AP-HP; Henri Mondor Hospital; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0465-1241","authenticated-orcid":false,"given":"H.","family":"Assier","sequence":"additional","affiliation":[{"name":"Department of Dermatology; AP-HP; Henri Mondor Hospital; Cr\u00e9teil France"},{"name":"Referral Center for Toxic Bullous Diseases and Severe Cutaneous Adverse Reactions; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gener","sequence":"additional","affiliation":[{"name":"Department of Dermatology; AP-HP; Henri Mondor Hospital; Cr\u00e9teil France"},{"name":"Referral Center for Toxic Bullous Diseases and Severe Cutaneous Adverse Reactions; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Paul","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; AP-HP; Henri Mondor Hospital; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Haddad","sequence":"additional","affiliation":[{"name":"Department of Dermatology; AP-HP; Henri Mondor Hospital; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Chosidow","sequence":"additional","affiliation":[{"name":"Department of Dermatology; AP-HP; Henri Mondor Hospital; Cr\u00e9teil France"},{"name":"Referral Center for Toxic Bullous Diseases and Severe Cutaneous Adverse Reactions; Cr\u00e9teil France"},{"name":"EA7379 EpidermE; UPEC; Cr\u00e9teil France"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil Val de Marne UPEC; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Wolkenstein","sequence":"additional","affiliation":[{"name":"Department of Dermatology; AP-HP; Henri Mondor Hospital; Cr\u00e9teil France"},{"name":"Referral Center for Toxic Bullous Diseases and Severe Cutaneous Adverse Reactions; Cr\u00e9teil France"},{"name":"EA7379 EpidermE; UPEC; Cr\u00e9teil France"},{"name":"Universit\u00e9 Paris Est Cr\u00e9teil Val de Marne UPEC; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[{"name":"Department of Dermatology; AP-HP; Henri Mondor Hospital; Cr\u00e9teil France"},{"name":"Referral Center for Toxic Bullous Diseases and Severe Cutaneous Adverse Reactions; Cr\u00e9teil France"},{"name":"EA7379 EpidermE; UPEC; Cr\u00e9teil France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"10.1111\/bjd.16738-BIB0001|bjd16738-cit-0001","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.chembiol.2004.07.010","article-title":"Dual effects of MLS antibiotics: transcriptional modulation and interactions on the ribosome","volume":"11","author":"Tsui","year":"2004","journal-title":"Chem Biol"},{"key":"10.1111\/bjd.16738-BIB0002|bjd16738-cit-0002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","article-title":"Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions","volume":"45","author":"Barbaud","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1111\/bjd.16738-BIB0003|bjd16738-cit-0003","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jbspin.2015.07.011","article-title":"Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment","volume":"83","author":"Bardin","year":"2016","journal-title":"Joint Bone Spine"},{"key":"10.1111\/bjd.16738-BIB0004|bjd16738-cit-0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5662\/wjm.v7.i1.25","article-title":"Patch testing and cross sensitivity study of adverse cutaneous drug reactions due to anticonvulsants: a preliminary report","volume":"7","author":"Shiny","year":"2017","journal-title":"World J Methodol"},{"key":"10.1111\/bjd.16738-BIB0005|bjd16738-cit-0005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1081-1206(10)60637-0","article-title":"Multiple-drug intolerance syndrome: clinical findings and usefulness of challenge tests","volume":"99","author":"Schiavino","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/bjd.16738-BIB0006|bjd16738-cit-0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0105-1873.2004.00280.x","article-title":"Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins","volume":"50","author":"Barbaud","year":"2004","journal-title":"Contact Dermatitis"},{"key":"10.1111\/bjd.16738-BIB0007|bjd16738-cit-0007","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"10.1111\/bjd.16738-BIB0008|bjd16738-cit-0008","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0536.1996.tb02364.x","article-title":"Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"35","author":"Wolkenstein","year":"1996","journal-title":"Contact Dermatitis"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16738","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16738\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:41:28Z","timestamp":1676382088000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/4\/978\/6753773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16738","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,20]]}}}